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ABSTRACT
Objectives: Mechanical complications of
median sternotomy may cause significant
morbidity and mortality in cardiac surgical
patients. This study was aimed at assessing the
role of Posthorax support vest (Epple, Inc.,
Vienna, Austria) in the prevention of sternal
complications and the improvement of
anatomical healing in patients at high risk for
mechanical sternal dehiscence after cardiac
surgery by mean of median sternotomy.
Methods: A prospective, randomized, study was
performed and 310 patients with predisposing
factors for sternal dehiscence after sternotomy
for cardiac surgery were included. The patients
were divided into two groups: patients who
received the Posthorax support vest after
surgery, and patients who did not. Primary
variables assessed included the incidence of
mechanical sternal complications, the quality
of sternal healing, the rate of re-operation, the
duration of hospitalization, rate and duration of
hospital, re-admission for sternal
complications. Secondary variables assessed
were the post-operative pain, the number of
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requests for supplemental analgesia and the
quality of life measured by means of the EQ-5D
format.
Results: Patients using vest demonstrated a
lower incidence of mechanical sternal
complications, a better anatomical sternum
healing, lower hospital stay, no re-operations
for sternal dehiscence before discharge and
lower re-admissions for mechanical sternal
complication. In addition, patients using a
vest reported a better quality of life with better
freedom from limitations in mobility, self-care,
and pain.
Conclusions: Our findings demonstrate that
the use of the Posthorax vest reduces
post-sternotomy mechanical complications
and improves the healing of the sternotomy,
the clinical course, and the post-operative
quality of life.
Keywords: Postoperative care; Quality of life;
Sternum; Surgery complications; Wound
healing; Dehiscence
INTRODUCTION
Mechanical complications of median
sternotomy are less frequent than infective
complications, but are a significant cause of
morbidity and, occasionally, of mortality in
patients undergoing cardiac surgery [1, 2]. These
complications can lead to a prolonged
hospitalization and sometimes require surgical
sternum revision [1, 2]. The increased
utilization of resources in terms of the
duration of hospitalization, staff work-hours,
use of materials and of infrastructure, result in
higher health care costs [1, 3]. The limitations
imposed on the reimbursement of health care
expenditures, especially in recent years, have
heightened the importance of preventing
post-sternotomy induced complications and
the need to reduce re-admissions and mean
hospitalization times whilst, at the same time,
be able to provide the best patient recovery and
subsequent quality of life [4]. Furthermore,
anatomically imperfect sternal healing may
cause chronic pain and affect the chest
mobility for many subsequent years [5–7].
The present research has a particular focus
on mechanical sternal dehiscence [8], a topic
only marginally treated by other papers [9–11].
We have adopted the Posthorax support vest
(Epple, Inc., Vienna, Austria) as its design
stabilizes the sternum following sternotomy,
relieves pressure on the suture wires and reduces
pain when breathing, coughing, and during
rehabilitation.
The aim of this study was to assess the
prevention of mechanical complications of
median sternotomy and the improvement of
the anatomical sternum healing by means of
the utilization of the Posthorax support vest
and to evaluate its impact on in-hospital
recovery in a group of patients at high risk for
sternal dehiscence.
METHODS
Eligibility Requirements and Recruitment
All procedures followed were in accordance
with the ethical standards of the responsible
national and institutional committee on
human experimentation and with the Helsinki
Declaration of 1964, as revised in 2013.
Informed consent was obtained from all
patients for being included in the study. From
February 15, 2010, to September 15, 2014, a
prospective, randomized, study was conducted.
The CONSORT flow diagram [12] was adopted
in order to assess the number of eligible patients
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who underwent a cardiac surgical procedure
with a median sternotomy (Fig. 1). We assess for
eligibility 2800 consecutive patients. Out of this
group, 2490 patients were excluded and 310
patients were included for randomization.
Exclusion criteria were the removal of the
chest drains after the 4th post-operative day,
the re-admission to the intensive care unit, the
need for adoption of mechanical ventilation for
any cause and the re-operation for
non-mechanically induced complications of
sternotomy including mediastinitis, wound,
sternal infection, or secondary sternal wound
infection and bleeding.
Within the cohort of 310 patients, 155
patients were allocated in group A (GA), in
Fig. 1 The CONSORT diagram showing the ﬂow of participants through each stage of a randomized study
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whom the Posthorax support vest was used
following the removal of the chest drains for
their entire hospitalization and until 90 days
after discharge, whereas the remaining 155
patients were allocated in group B (GB), in
whom no support vests were used after surgery.
A power analysis was performed to
determine the adequate sample size. Based on
preliminary study results [9, 10], and an
estimated incidence of cumulative
complication rates of 3% for group A and 10%
for group B, we have obtained a power value of
0.7 with a sample size of 152 patients.
The follow-up has been 100% complete and
100% of patients have been included in
statistical analysis. Both groups had identical
inclusion criteria and were deemed at high risk
for mechanically induced sternal dehiscence if
they presented at least one of the following
recognized risk factors for complications of
median sternotomy: any type of diabetes
mellitus (regardless of duration of disease
requiring diet modification, oral or insulin
therapy), obesity [body mass index (BMI) C25],
bilateral internal mammary artery (BIMA)
harvesting, and chronic obstructive pulmonary
disease (COPD). The latter was defined as
chronic lung disease (emphysema, chronic
bronchitis) of any severity (FEV1 \75% of
predicted, and/or on chronic steroid or
bronchodilator therapy) preoperatively
diagnosed by a respiratory specialist [9–11, 13].
Randomization of patients and assignment
to each study group was performed immediately
after the chest drains removal via a random
number generator program. The study variables
recorded for both groups were: the need for
re-operation for mechanically induced sternum
complications, the number of requests for
analgesic supplementation, the quality of life
as measured by the EQ-5D format [14], which
was administered to patients at the moment of
discharge, the duration of hospitalization (in
days), the number of patients that were
re-admitted only for post-sternotomy
mechanically induced complications at any
time from the start of the study until the end
of follow-up and their length of stay following
re-admission (in days).
Being that this an monocentric study, no
trial registry was created to perform our
analysis; data were deposited in/or recovered
from patients’ medical records.
Sternum Closure
Routine sternum closure as per institutional
practice was followed in all patients. Seven
stainless-steel sternum wire sutures were
passed though the sternum at approximately
1 cm apart on each side and were tied and
twisted avoiding excessive tension. No patient
underwent sternum closure by means of
Robicsek’s technique [15]. Patients received an
identical peri-operative prophylactic antibiotic
regime with cefuroxime 3000 mg/day (adjusted
accordingly with renal function) until the
removal of the central venous line usually on
the second post-operative day.
Any activity precaution after sternotomy was
given to patients in according with
well-established clinical and therapeutical
practices.
Analgesia Protocols
All patients in both groups received a similar
analgesic protocol, which included 4 mg of
morphine sulphate IV and 500 mg of
paracetamol IV every 8 h with 4 mg of
ondansetron IV every 12 h during the first
48 h post-operatively. Subsequently, the
patients received 500 mg paracetamol IV every
8 h only. The additional on-demand analgesic
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supplementation to the standard analgesic
protocol was 500 mg of paracetamol IV up to a
maximum total of 2500 mg/day and afterwards
30 mg of ketorolac IV every 12 h. Pain levels
were assessed every time a patient requested
supplemental analgesia by using the visual
analogue scale (VAS) to obtain a score [16].
Anatomical Recovery Evaluation
All patients underwent a routine
anterior-posterior chest radiograph at
discharge in order to assess anatomical
sternum recovery by evaluating the
sternotomy line. Findings such as a
mid-sternum line of lucency[2 mm indicating
sternum diastasis [17], any sternum wire
displacement, or any obvious interruption/
dislocation were recorded. Given that the
maximum dehiscence risk occurs during the
first post-operative week, a single chest
radiogram at discharge was deemed adequate
to assess sternum diastasis and in addition to
inspection of the thorax to evaluate the
sternum instability and/or pain at coughing.
The physician involved in evaluating the chest
X-rays was blinded according to treatment
group.
During the 90-day follow-up period after
discharge, patients were monitored at their
visits to the outpatient clinic or by telephone
interviews focusing on sternal wound problems
after discharge.
Posthorax Support Vest
The Posthorax sternum support vest
(Posthorax sternum support vest; Epple, Inc.,
Vienna, Austria) is of a patented design with
pressure and stabilization aimed specifically
towards the sternum. It provides
anterior-posterior stabilization of the thorax,
instead of simple lateral compression, while
holding the two halves of the sternum in
place. Two pads placed longitudinally on each
side of the sternum, ergonomically fitted for
males and females, prevent intrinsic
movement of the two sternum halves and
serve as shock absorbers when the patient
coughs or breathes deeply, and also support
the sternum when mobilizing in and out of
bed. Its design is non-restrictive so as to allow
for maximal respiratory effort and
expectoration without significantly
contributing to respiratory complications such
post-operative pneumonia. Moreover, the
build-in individual sizing and upper strap
supports stop the vest from sliding into and
compressing the abdomen.
Statistical Analysis
Continuous, normally distributed variables are
presented as mean ± standard deviation (SD).
Categorical variables are expressed as absolute
numbers and percentages. Comparisons
between patient groups were performed using
the v2 test and Fisher’s exact test for categorical
variables, while for continuous variable the
unpaired t test or the Mann–Whitney U test
were used. In addition to direct group
comparisons, subgroup comparisons according
to individual variables of interest (age C 70,
weight C 80 kg, BMI C 25, males, BIMA
harvesting and those with COPD) were
performed. p values less than 0.05 were
considered statistically significant. For all
statistical comparisons, the SPSS statistical
software package for Windows (SPSS Inc.,
Chicago, IL, USA) was used.
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RESULTS
Patient clinical and operative characteristics are
shown in Table 1. The average number of
requests for supplemental analgesia was lower
in group A compared to group B but the
difference did not reach statistical significance
(1.6 ± 0.4 vs. 2.0 ± 0.5, p = NS) (Table 2).
However, a subgroup analysis demonstrated a
significant decrease in requests for
supplemental analgesia in favor of group A in
the following subgroups: those of age\70 years
(1.4 ± 0.1 vs. 2.3 ± 0.2, p = 0.002), males
(1.3 ± 0.2 vs. 2.1 ± 0.1, p = 0.005), patients
Table 1 Patient clinical and operative characteristics (%





Age (years) 67.5 ± 12.0 70.4 ± 14.0
Male 109 (70%) 101 (65%)
Female 46 (30%) 54 (35%)
Weight (kg) 84.3 ± 17.2 78.4 ± 13.4
BMI 30.0 ± 11.1 28.0 ± 8.2
COPD 57 (37%) 61 (39%)
Procedural subgroups
CABG 74 (48%) 70 (45%)
1 graft 24 (15%) 25 (16%)
2 grafts 21 (14%) 23 (14.8%)
3 grafts 28 (18%) 24 (15%)
4 grafts 8 (5%) 6 (4%)
LIMA graft 41 (26%) 43 (28%)
BIMA grafts 40 (26%) 35 (23%)
AVR or MVR 57 (37%) 60 (39%)
AAR 8 (5%) 7 (5%)
Combined
surgery
16 (10%) 18 (12%)
BMI body mass index, BIMA bilateral mammary arteries,
COPD chronic obstructive pulmonary disease, AVR aortic
valve replacement, CABG coronary artery bypass grafting,
MVR mitral valve replacement or repair, LIMA left
internal mammary artery, AAR ascending aorta and/or
arch replacement
Table 2 Average number of requests for supplemental








1.6 ± 0.4 2.0 ± 0.5 0.07
Clinical subgroups
Age C70 1.8 ± 0.7 1.7 ± 0.8 0.085
Age\70 1.4 ± 0.1 2.3 ± 0.2 0.002
Sex
Male 1.3 ± 0.2 2.1 ± 0.1 0.005
Female 1.9 ± 0.6 1.9 ± 0.9 –
Weight
C80 kg
1.7 ± 0.1 3.6 ± 0.2 0.001
Weight
\80 kg
1.4 ± 0.3 1.6 ± 0.3 0.066
BMI C25 1.6 ± 0.2 3.3 ± 0.3 0.005
BMI\25 2.0 ± 0.2 1.8 ± 0.2 0.074
COPD 1.9 ± 0.1 4.2 ± 0.2 0.001
Procedural subgroups
CABG 1.4 ± 0.3 1.6 ± 0.5 0.082
1 graft 1.2 ± 0.2 1.4 ± 0.4 0.073
2 grafts 1.4 ± 0.3 1.8 ± 0.6 0.065
3 grafts 1.6 ± 0.4 1.6 ± 0.5 –
4 grafts 1.4 ± 0.3 1.6 ± 0.5 0.082
LIMA
graft
1.7 ± 0.6 2.3 ± 0.7 0.055
BIMA
grafts
1.4 ± 0.1 3.2 ± 0.2 0.001
AVR 1.6 ± 0.2 1.9 ± 0.4 0.070
MVR 1.6 ± 0.7 1.7 ± 0.3 0.089
AAR 1.9 ± 0.4 2.1 ± 0.7 0.078
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with weight C80 kg (1.7 ± 0.1 vs. 3.6 ± 0.2,
p = 0.001) or with a BMI C25 (1.6 ± 0.2 vs.
3.3 ± 0.3, p = 0.005), those with COPD
(1.9 ± 0.1 vs. 4.2 ± 0.2, p = 0.001), and those
which underwent BIMA harvesting (1.4 ± 0.1
vs. 3.2 ± 0.2, p = 0.001) (Table 2). The mean
VAS pain score was significantly lower in group
A than in group B (2.4 ± 0.3 vs. 3.4 ± 0.6,
p = 0.02), a difference which in the subgroup
analysis was more pronounced in the following
subgroups: those of age\70 years (2.4 ± 0.2 vs.
4.3 ± 0.4, p = 0.001), males (2.2 ± 0.1 vs.
3.6 ± 0.3, p = 0.005), patients with weight
C80 kg (2.1 ± 0.3 vs. 4.2 ± 0.1, p = 0.001) or
with BMI C25 (2.3 ± 0.2 vs. 4.3 ± 0.2,
p = 0.001), those with COPD (3.1 ± 0.5 vs.
4.7 ± 0.6, p = 0.002), and those which
underwent BIMA harvesting (1.8 ± 0.1 vs.
4.6 ± 0.7, p\0.001) (Table 3). Given the
overall significant difference demonstrated
that there was a significant reduction in pain
scores between group A and group B across all
types of surgery including coronary artery
bypass grafting (CABG), (1.8 ± 0.4 vs.
3.1 ± 0.6, p = 0.01), aortic valve replacement
(AVR), (2.8 ± 0.4 vs. 3.7 ± 0.2, p = 0.05), mitral
valve replacement or repair (MVR), (2.4 ± 0.2
vs. 3.4 ± 0.4, p = 0.02), ascending aorta/arch
replacement (AAR), (2.8 ± 0.3 vs. 3.6 ± 1.1,
p = 0.05), and in combined surgery (2.3 ± 0.3
vs. 3.4 ± 0.3, p = 0.02) (Table 3). The EQ-5D
analysis of post-operative quality of life
demonstrated significantly better results in
terms of freedom of limitations in mobility (70
vs. 30%, p = 0.001) and self care (73.5 vs. 46.4%,
p = 0.002), in totally limited activity (10.3 vs.
24.5%, p = 0.005), in freedom from pain (43.2
vs. 10.3%, p = 0.001), and in absence of anxiety
(49.7 vs. 29.6%, p = 0.05) in group A compared
to group B (Table 4). At discharge there were no
cases of re-operation for mechanically induced
sternum complication in group A vs. seven cases
in group B (Table 5). At discharge, a sternotomy
stripe of lucency[2 mm was observed in seven
patients in group A and in 31 patients in group
B (4.5 vs. 20%, p = 0.005), and a clear







Overall mean 2.4 ± 0.3 3.4 ± 0.6 0.02
Clinical subgroups
Age C70 2.4 ± 0.4 2.5 ± 0.8 0.086
Age\70 2.4 ± 0.2 4.3 ± 0.4 0.001
Sex
Male 2.2 ± 0.1 3.6 ± 0.3 0.005
Female 2.6 ± 0.5 3.2 ± 0.9 0.059
Weight
C80 kg
2.1 ± 0.3 4.2 ± 0.1 0.001
Weight
\80 kg
2.7 ± 0.3 2.6 ± 1.1 0.071
BMI C25 2.3 ± 0.2 4.3 ± 0.2 0.001
BMI\25 2.5 ± 0.4 2.5 ± 1.0 –
COPD 3.1 ± 0.5 4.7 ± 0.6 0.002
Procedural subgroups
CABG 1.8 ± 0.4 3.1 ± 0.6 0.01
1 graft 1.6 ± 0.2 2.3 ± 1.0 0.061
2 grafts 2.0 ± 0.6 2.8 ± 1.2 0.057
3 grafts 1.7 ± 0.8 2.4 ± 0.4 0.072
4 grafts 1.9 ± 0.6 2.9 ± 0.8 0.05
LIMA graft 1.8 ± 0.7 1.6 ± 0.5 0.077
BIMA grafts 1.8 ± 0.1 4.6 ± 0.7 0.001
AVR 2.8 ± 0.4 3.7 ± 0.2 0.05
MVR 2.4 ± 0.2 3.4 ± 0.4 0.02
AAR 2.8 ± 0.3 3.6 ± 1.1 0.05
Combined
surgery
2.3 ± 0.3 3.4 ± 0.3 0.02
For the legend, see Table 1
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interruption/dislocation of the sternotomy line
was observed in eight patients in group B and
none in group A (5.2 vs. 0%) (Table 5). The
average days of in-hospital stay were
significantly lower in group A compared to
group B (7 ± 2.7 vs. 12 ± 3.4, p = 0.02) (Table 5).
None of the patients in group A vs. three
patients of group B developed post-operative
pneumonia. In group B, 16 patients were
re-admitted during the follow-up period for
post-sternotomy mechanically induced
complications vs. six patients in group A (3.9
vs. 10.3%, p = 0.05) (Table 5). The mean post
re-admission hospital stay was significantly
lower in group A (8 ± 3.2 days) vs. group B
(24 ± 7 days, p = 0.05) (Table 5). There were no
other complications of any kind reported with
the usage of the Posthorax sternum support vest
in group A patients. The mean follow-up was
2.4 ± 2.1 years (range, 0.83–5.25 years).
Freedom from mechanical events at 5 years
was 95.8 ± 6.1 in GA and 84.7 ± 5.3 in GB
(p\0.001).
DISCUSSION
The Posthorax vest is the latest technological
generation of sternum support corsets [18]. It
has been designed to stabilize the sternum
following sternotomy so as to avoid excessive
stress on the sternum wires during bone healing
[17]. It differs from other previous vest designs
because its structure is open in the front and is
not based on a circumferential elastic band
design making it less restrictive [18]. This open
structure is also more hygienic, as it avoids
compression and contamination of the skin
wound. The non-elastic band structure avoids
harmful continuous compression on the thorax
and interference with respiratory effort and
only provides support during excessive chest
stress such as when coughing, mobilizing, or
performing rehabilitation exercises [18]. In
other words, the patient’s chest is free to move
during breathing and is only supported during
excessive or non-physiological movement, thus
reducing the potential risk of respiratory
complications. None of the patients who
utilized the Posthorax support vest in our
series developed post-operative pneumonia or
any other kind of complications associated with
its use. Our findings concerning the incidence
of respiratory complications with Posthorax
support vest adoption is not statistically







Free of limitations 108 (70%) 47 (30%) 0.001
Partially limited 47 (30%) 62 (40%) 0.058
Totally limited 0 46 (30%) –
Self care
Free of limitations 114 (74%) 72 (46%) 0.002
Partially limited 41 (27%) 44 (28%) 0.32
Totally limited 0 39 (25%) –
Usual activities
Free of limitations 77 (50%) 61 (39%) 0.062
Partially limited 62 (40%) 56 (36%) 0.12
Totally limited 16 (10%) 38 (25%) 0.005
Pain/discomfort
Absent 67 (43%) 16 (10%) 0.001
Moderate 88 (57%) 102 (66%) 0.24
Extreme 0 37 (24%) –
Anxiety/depression
Absent 77 (50%) 46 (27%) 0.05
Moderate 78 (50%) 87 (56%) 0.19
Extreme 0 22 (14%) –
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significant. Statistically significant clinical
advantages were observed in the group of
patients that used the Posthorax support vest
following sternotomy, such as less mechanical
complications, better sternal healing, lower
hospitalization, less pain and lower analgesic
medication requirements, better comfort, and
earlier mobilization and autonomy. These
clinical improvements may be attributed to
the improved sternum stability in group A
that is provided by the Posthorax support vest
without limitation on breathing and this can be
translated in better patient comfort and
mobility and lower incidence of mechanically
induced sternum complications, but quite
importantly in our ‘‘economic conscious’’ age
can mean lower associated healthcare costs. Our
findings are supported by other randomized
studies from the literature [9, 18, 19]. However,
these studies are multicentric and included
infective and non-infective sternal
complications and furthermore they did not
do an extensive subgroup analysis on patients
with a high risk for sternal complications. As
recently reported by Heilmann et al. [19],
superficial healing disorders occur in 3.3% of
unselected patients after sternotomy for cardiac
surgery, while 2.5% developed deep wound
complications and 7.9% of them died
in-hospital. No pathogen was identified and
the wound appeared uninfected in 21% of all
deep complications or 0.05% of all patients.
Study Limitations
The study presents a number of limitations:
firstly, we used EQ-5D format only as a
descriptive tool because the time of
observation of the study has been limited only
to the hospital stay in order to eliminate bias
related with differences in managing or
behavior of patients after discharge from the
hospital. To overcome this problem, we
assumed the EQ-5D of the control group as
the baseline. Furthermore, the use of baseline
data inside the groups is not proper if we
consider the fast changes of health status
during the early postoperative period, a factor
that makes EQ 5 as not reliable. Another
limitation might be the antalgic protocol of
the study. Our institution has not arbitrarily
implemented this protocol, but it followed the
directives of the ‘‘Hospital without pain’’ project
that has been established by the Italian National
Health Service (NHS) within all specialties for all
hospitals. A further potential limitation is the
Table 5 Outcomes (number event or mean ± SD)
Group A (n5 155) Group B (n5 155) p value
Post operative length of stay (days) 7 ± 2.7 12 ± 3.4 0.02
Re-admission for mechanical complications 6 16 0.05
Re-operation for mechanical complications 0 7 –
Length of stay following re-admission 8 ± 3.2 24 ± 7.0 0.05
Sternotomy line[2 mm at discharges 7 31 0.005
Dislocation of sternotomy line 0 8 –
Follow-up (mean, 2.4 ± 2.1 years, range, 0.83–5.25 years)
5 years freedom from mechanical events (%)
95.8 ± 6.1 84.7 ± 5.3 0.001
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exclusion of all events at risk for infections and
mediastinitis. It should, however, be stressed
that the end point of the study is the prevention
of mechanical complications of sternotomy
with this vest and it has been adopted because
the vest only acts mechanically. Thus, we have
decided to eliminate this potential bias for
powering the study. As mediastinitis is now a
rare complication in cardiac surgery, the
exclusion of mediastinitis is not a significant
limitation of the study when we consider the
dimension of our series. Finally, the lack of
information regarding the techniques of sternal
closure, we feel this aspect is not a significant
limitation because both groups have been
managed by the same surgical staff so that
distributions of surgeon-dependent and
patient-dependent criteria have been ‘‘de
facto’’ random. Furthermore, it should be
considered that in the same patient, the
surgeon could use both kinds of wires in
different segments of the sternotomy for
technical reasons.
To follow patients in their use of the
Posthorax vest during 90 days after discharge
is very difficult and this may be considered
another important limitation point. Indeed,
during this period we have asserted the
continuous use of the vest by outpatient visit
or telephone interview. Of course, this
procedure may be considered to be affected by
limited veracity; however, the results obtained
in the present study seem to indicate a
continuous use of the vest by the patients.
CONCLUSIONS
The data of the present study show that
mechanical sternal complications play a
significant role in the genesis of
poststernotomy complications and confirm
they remain a challenge to cardiac surgery so
that more efforts seem mandatory to decrease
their significant morbidity and the costs of
prolonged treatment. The original design of
this study allows to evaluate for the first time
without bias the effectiveness of this new
sternal support corset to prevent mechanical
sternal complications, to reduce pain and
hospitalization, and to increase the quality of
life in the postoperative period.
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